Recombinant bone morphogenetic protein-2 attenuates colorectal cancer progression by orchestrating Hippo pathway activation, Yes-associated protein inhibition, and epithelial--mesenchymal transition suppression.

Saved in:

Bibliographic Details
Title:	Recombinant bone morphogenetic protein-2 attenuates colorectal cancer progression by orchestrating Hippo pathway activation, Yes-associated protein inhibition, and epithelial--mesenchymal transition suppression.
Authors:	Wu, Yanling¹, Lee, Na-Ri^2,3, Liu, Yu Chuan¹, Kim, Min Sun⁴, Hwang, Seongwon⁵, Kim, Bumseok⁵, Lee, Kwang-Bok⁶ osdr2815@naver.com, Kim, Soo Mi^1,3 soomikim@jbnu.ac.kr
Source:	Korean Journal of Physiology & Pharmacology. Jul2026, Vol. 30 Issue 4, p361-375. 15p.
Database:	Academic Search Ultimate

Description
ISSN:	12264512
DOI:	10.4196/kjpp.25.369